当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Hydromorphone Hydrochloride
HUMAN COMPOUNDED DRUG
73177-104
STAQ Pharma Inc
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
73177-104-05
Hydromorphone Hydrochloride
HUMAN COMPOUNDED DRUG
73177-104
STAQ Pharma Inc
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
73177-104-01
Hydromorphone Hydrochloride
HUMAN COMPOUNDED DRUG
73177-104
STAQ Pharma Inc
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
73177-104-03
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73177-102
STAQ Pharma Inc
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL
73177-102-01
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73177-102
STAQ Pharma Inc
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL
73177-102-05
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73177-102
STAQ Pharma Inc
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL
73177-102-02
Papeverine HCl/Phenoloamine Mesylate/Prostaglandin E1/Atropine Sulfate
HUMAN COMPOUNDED DRUG
72627-2504
Empower Pharmacy
2021/2/1 0:00:00
PAPAVERINE HYDROCHLORIDE; PHENTOLAMINE MESYLATE; ALPROSTADIL; ATROPINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 mg/1 mL; 4 mg/1 mL; .04 mg/1 mL; .4 mg/1 mL
72627-2504-3
Phenylephrine HCl
HUMAN COMPOUNDED DRUG
72627-2502
Empower Pharmacy
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
72627-2502-7
Testosterone Cypionate
HUMAN COMPOUNDED DRUG
72627-2100
Empower Pharmacy
2021/2/1 0:00:00
TESTOSTERONE CYPIONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 mL
72627-2100-1
Ketamine
HUMAN COMPOUNDED DRUG
72627-4010
Empower Pharmacy
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg
72627-4010-9
Ketamine
HUMAN COMPOUNDED DRUG
72627-4003
Empower Pharmacy
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/1 mL
72627-4003-7
Ketamine
HUMAN COMPOUNDED DRUG
72627-4003
Empower Pharmacy
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/1 mL
72627-4003-3
Ascorbic Acid
HUMAN COMPOUNDED DRUG
72627-2404
Empower Pharmacy
2021/2/1 0:00:00
ASCORBIC ACID
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
500 mg/1 mL
72627-2404-1
Phenylephrine 1MG
HUMAN COMPOUNDED DRUG
68985-049
LEESAR INC
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
68985-049-91
Norepinephrine 8MG
HUMAN COMPOUNDED DRUG
68985-931
LEESAR INC
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 mg/250 mL
68985-931-98
Azithromycin 500mg
HUMAN COMPOUNDED DRUG
68985-112
LEESAR INC
2021/2/1 0:00:00
AZITHROMYCIN ANHYDROUS
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg/1 mL
68985-112-91
SUCCINYLCHOLINE 20MG/ML
HUMAN COMPOUNDED DRUG
68985-629
LEESAR INC
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
68985-629-95
SUCCINYLCHOLINE 20MG/ML
HUMAN COMPOUNDED DRUG
68985-629
LEESAR INC
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
68985-629-91
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73177-102
STAQ Pharma Inc
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL
73177-102-03
Phenylephrine
HUMAN COMPOUNDED DRUG
73177-108
STAQ Pharma Inc
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 ug/1 mL
73177-108-03
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3